0001231919-25-000182.txt : 20250903 0001231919-25-000182.hdr.sgml : 20250903 20250903161133 ACCESSION NUMBER: 0001231919-25-000182 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250903 DATE AS OF CHANGE: 20250903 EFFECTIVENESS DATE: 20250903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Daymark Health, Inc. CENTRAL INDEX KEY: 0002034499 ORGANIZATION NAME: EIN: 882955781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-556542 FILM NUMBER: 251289867 BUSINESS ADDRESS: STREET 1: 548 MARKET STREET, SUITE 17462 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (254) 315-0338 MAIL ADDRESS: STREET 1: 548 MARKET STREET, SUITE 17462 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 D 1 primary_doc.xml X0708 D LIVE 0002034499 Daymark Health, Inc. 701 E. Cathedral Rd, Suite 45 #3067 Philadelphia PA PENNSYLVANIA 19128 866-799-7855 DELAWARE Iron NewCo, Inc. None Corporation true 2022 Justin Bekelman c/o Daymark Health, Inc. 701 E. Cathedral Rd, Suite 45 #3067 Philadelphia PA PENNSYLVANIA 19128 Executive Officer Director Ambar Bhattacharyya c/o Daymark Health, Inc. 701 E. Cathedral Rd, Suite 45 #3067 Philadelphia PA PENNSYLVANIA 19128 Director Roy Beveridge c/o Daymark Health, Inc. 701 E. Cathedral Rd, Suite 45 #3067 Philadelphia PA PENNSYLVANIA 19128 Director Paul Dufault c/o Daymark Health, Inc. 701 E. Cathedral Rd, Suite 45 #3067 Philadelphia PA PENNSYLVANIA 19128 Executive Officer Aman Mahajan c/o Daymark Health, Inc. 701 E. Cathedral Rd, Suite 45 #3067 Philadelphia PA PENNSYLVANIA 19128 Director Kelsey Maguire c/o Daymark Health, Inc. 701 E. Cathedral Rd, Suite 45 #3067 Philadelphia PA PENNSYLVANIA 19128 Director Other Health Care Decline to Disclose 06b false 2025-08-19 false true false 0 26000000 26000000 0 Total Offering Amount includes $6,000,000 of convertible securities. false 7 0 0 0 false Daymark Health, Inc. /s/ Justin Bekelman Justin Bekelman Chief Executive Officer 2025-09-03